LEU001 / Leucid Bio 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  LEU001 / Leucid Bio
    Trial completion date, Trial primary completion date:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Oct 9, 2024   
    P1,  N=30, Recruiting, 
    Trial completion date: Dec 2023 --> Jan 2025 | Trial primary completion date: Dec 2023 --> Dec 2024
  • ||||||||||  LEU001 / Leucid Bio
    Phase classification, Trial completion date, Trial primary completion date:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Apr 6, 2022   
    P1,  N=30, Recruiting, 
    These data demonstrate the safe intratumoral administration of T4 immunotherapy in advanced HNSCC. Phase classification: P1/2 --> P1 | Trial completion date: Apr 2022 --> Dec 2023 | Trial primary completion date: Apr 2022 --> Dec 2023
  • ||||||||||  LEU001 / Leucid Bio
    Trial completion date, Trial primary completion date:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Sep 2, 2020   
    P1/2,  N=30, Recruiting, 
    Phase classification: P1/2 --> P1 | Trial completion date: Apr 2022 --> Dec 2023 | Trial primary completion date: Apr 2022 --> Dec 2023 Trial completion date: Apr 2020 --> Apr 2022 | Trial primary completion date: Feb 2020 --> Apr 2022
  • ||||||||||  LEU001 / Leucid Bio
    Phase classification, Trial completion date, Trial primary completion date:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Feb 27, 2019   
    P1/2,  N=30, Recruiting, 
    Trial completion date: Apr 2020 --> Apr 2022 | Trial primary completion date: Feb 2020 --> Apr 2022 Phase classification: P1 --> P1/2 | Trial completion date: Dec 2019 --> Apr 2020 | Trial primary completion date: Jun 2019 --> Feb 2020
  • ||||||||||  LEU001 / Leucid Bio
    Trial primary completion date, IO biomarker:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Aug 18, 2017   
    P1,  N=30, Recruiting, 
    Phase classification: P1 --> P1/2 | Trial completion date: Dec 2019 --> Apr 2020 | Trial primary completion date: Jun 2019 --> Feb 2020 Trial primary completion date: Jun 2017 --> Jun 2019
  • ||||||||||  LEU001 / Leucid Bio
    Enrollment open, IO biomarker:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Jul 22, 2015   
    P1,  N=30, Recruiting, 
    Trial primary completion date: Jun 2017 --> Jun 2019 Not yet recruiting --> Recruiting
  • ||||||||||  LEU001 / Leucid Bio
    Trial initiation date, Trial primary completion date, IO biomarker:  Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (clinicaltrials.gov) -  Apr 14, 2015   
    P1,  N=30, Not yet recruiting, 
    Not yet recruiting --> Recruiting Initiation date: Jun 2013 --> Jun 2015 | Trial primary completion date: Jun 2015 --> Jun 2017